We are live on ! Find out more
FAS

Formuepleje A/S Portfolio holdings

AUM $1.28B
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+24.24%
3 Year Est. Return
+75.12%
5 Year Est. Return
+78.91%
10 Year Est. Return
+321.64%
AUM
$761M
AUM Growth
+$21M
Cap. Flow
+$2.5M
Cap. Flow %
0.33%
Top 10 Hldgs %
55.25%
Holding
74
New
4
Increased
17
Reduced
36
Closed
9

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$23.1M
2
SCI icon
Service Corp International
SCI
+$20.4M
3
CVS icon
CVS Health
CVS
+$9.74M
4
NKE icon
Nike
NKE
+$5.79M
5
ELV icon
Elevance Health
ELV
+$4.69M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$17M
2
PX
Praxair Inc
PX
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$15.5M
4
ADP icon
Automatic Data Processing
ADP
+$8.04M
5
CME icon
CME Group
CME
+$7.44M

Sector Composition

Rank Sector Weight
1 Financials 27.4%
2 Healthcare 24%
3 Consumer Discretionary 13.42%
4 Technology 9.79%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCI icon
1
Service Corp International
SCI
$11.4B
$65.8M 8.65%
2,317,050
+765,800
+49% +$20.4M
MSFT icon
2
Microsoft
MSFT
$3.75T
$61.9M 8.13%
995,342
-65,300
-6% -$3.93M
UNH icon
3
UnitedHealth
UNH
$354B
$48M 6.31%
299,853
-103,600
-26% -$15.5M
ELV icon
4
Elevance Health
ELV
$86.8B
$41.2M 5.41%
286,248
+35,000
+14% +$4.69M
DOV icon
5
Dover
DOV
$27.3B
$40.7M 5.35%
672,333
+17,084
+3% +$987K
TEVA icon
6
Teva Pharmaceuticals
TEVA
$44B
$34.9M 4.59%
962,700
+578,000
+150% +$23.1M
SPGI icon
7
S&P Global
SPGI
$128B
$34.5M 4.54%
320,915
-141,900
-31% -$17M
GILD icon
8
Gilead Sciences
GILD
$184B
$31.4M 4.12%
438,279
+33,200
+8% +$2.47M
SLB icon
9
SLB Ltd
SLB
$82.1B
$31.2M 4.1%
371,675
+14,700
+4% +$1.2M
V icon
10
Visa
V
$709B
$31M 4.07%
396,760
+21,000
+6% +$1.69M
MCO icon
11
Moody's
MCO
$88.2B
$29.3M 3.85%
311,070
+18,200
+6% +$1.84M
GS icon
12
Goldman Sachs
GS
$303B
$28.2M 3.7%
117,730
-1,500
-1% -$305K
AXP icon
13
American Express
AXP
$225B
$26.4M 3.47%
356,427
-6,300
-2% -$436K
NKE icon
14
Nike
NKE
$56.9B
$24.9M 3.28%
490,458
+112,800
+30% +$5.79M
WFC icon
15
Wells Fargo
WFC
$257B
$24.4M 3.2%
441,900
+10,600
+2% +$533K
PG icon
16
Procter & Gamble
PG
$333B
$24.2M 3.18%
288,090
– –
OMC icon
17
Omnicom Group
OMC
$24.2B
$23.4M 3.07%
274,688
-4,700
-2% -$394K
C icon
18
Citigroup
C
$223B
$21.7M 2.85%
365,490
+12,700
+4% +$685K
SRCL
19
DELISTED
Stericycle Inc
SRCL
$21.7M 2.85%
281,560
-2,400
-0.8% -$181K
BIIB icon
20
Biogen
BIIB
$32.7B
$17.7M 2.33%
62,400
-400
-0.6% -$119K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.13T
$17.4M 2.28%
450,000
-4,000
-0.9% -$156K
BLK icon
22
Blackrock
BLK
$181B
$13.1M 1.72%
34,357
-100
-0.3% -$36.7K
CSCO icon
23
Cisco
CSCO
$441B
$12M 1.58%
398,023
– –
CVS icon
24
CVS Health
CVS
$119B
$9.5M 1.25%
+120,400
New +$9.74M
ENIA
25
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$9.37M 1.23%
1,141,051
-16,000
-1% -$133K
1
2 3

Similar funds

UFM
Ursa Fund Management Danville, California $1.28B AUM 89.08% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
MTC
McDaniel Terry & Co Austin, Texas $1.28B AUM 18.17% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.28B AUM 32% 1-Year Est. Return
IWA
IBEX Wealth Advisors Bedminster, New Jersey $1.28B AUM 61% 1-Year Est. Return
SFM
Stack Financial Management Whitefish, Montana $1.28B AUM 18.06% 1-Year Est. Return
AHC
Anderson Hoagland & Co St Louis, Missouri $1.28B AUM 29.05% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.27B AUM 23.08% 1-Year Est. Return

Formuepleje A/S's Q4 2016 Portfolio in Review

As of Q4 2016, Formuepleje A/S held 74 positions worth $761M, up 2.8% from $740M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Formuepleje A/S's Q4 2016 filing shows 4 new, 17 increased, 36 reduced and 9 closed positions. Its largest new stake was CVS Health: 120,400 shares worth $9.5M. The largest sale was S&P Global, an estimated $17M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Formuepleje A/S's largest Q4 2016 buy was CVS Health: 120,400 shares worth $9.5M.
  • Formuepleje A/S added most to Teva Pharmaceuticals in Q4 2016, an estimated $23.1M increase.
  • Formuepleje A/S's biggest Q4 2016 reduction was S&P Global, cutting an estimated $17M.
  • Formuepleje A/S fully exited Praxair Inc in Q4 2016, selling an estimated $15.9M.
  • Formuepleje A/S's ten largest holdings make up 55% of its $761M portfolio in Q4 2016.
  • Formuepleje A/S opened 4 new positions and closed 9 in Q4 2016.
  • Formuepleje A/S's portfolio value rose 2.8% quarter-over-quarter to $761M.

Based on Formuepleje A/S's 13F filing for Q4 2016, filed 27 Aug 2026.